+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Protein Kinase C (PKC) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Protein Kinase C (PKC) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Oral Anti-diabetes Drugs Market - Growth, Trends, and Forecasts (2020 - 2025) - Product Thumbnail Image

Oral Anti-diabetes Drugs Market - Growth, Trends, and Forecasts (2020 - 2025)

  • Report
  • August 2020
  • 150 Pages
  • Global
From
Overactive Bladder - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Overactive Bladder - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 130 Pages
  • Global
From
Regenerative Therapies Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Regenerative Therapies Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • August 2024
  • 93 Pages
  • Global
From
Ureter Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ureter Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 150 Pages
  • Global
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Retinitis Pigmentosa (Retinitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Retinitis Pigmentosa (Retinitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 206 Pages
  • Global
From
Endometriosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Endometriosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 430 Pages
  • Global
From
Genitourinary Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Genitourinary Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 200 Pages
  • Global
From
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 871 Pages
  • Global
From
Polycystic Ovarian Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Polycystic Ovarian Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • August 2023
  • 739 Pages
  • Global
From
Bioinformatics Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Bioinformatics Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
Dermatology Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Dermatology Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 250 Pages
  • Global
From
Stem Cell Therapy Contract Manufacturing Market Report 2023-2033 - Product Thumbnail Image

Stem Cell Therapy Contract Manufacturing Market Report 2023-2033

  • Report
  • September 2023
  • 310 Pages
  • Global
From
Dry (Atrophic) Macular Degeneration Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Dry (Atrophic) Macular Degeneration Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • August 2023
  • 106 Pages
  • Global
From
Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 3237 Pages
  • Global
From
mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035: Distribution by Application Area, Target Disease Indication and Geographical Regions - Product Thumbnail Image

mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035: Distribution by Application Area, Target Disease Indication and Geographical Regions

  • Report
  • September 2024
  • 343 Pages
  • Global
From
Age Related Macular Degeneration Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update - Product Thumbnail Image

Age Related Macular Degeneration Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update

  • Report
  • July 2023
  • 808 Pages
  • Global
From
Wet (Neovascular/Exudative) Macular Degeneration Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update - Product Thumbnail Image

Wet (Neovascular/Exudative) Macular Degeneration Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update

  • Report
  • July 2023
  • 457 Pages
  • Global
From
Loading Indicator